154 related articles for article (PubMed ID: 33333043)
1. Lumican, pro-tumorigenic or anti-tumorigenic: A conundrum.
Appunni S; Rubens M; Ramamoorthy V; Anand V; Khandelwal M; Saxena A; McGranaghan P; Odia Y; Kotecha R; Sharma A
Clin Chim Acta; 2021 Mar; 514():1-7. PubMed ID: 33333043
[TBL] [Abstract][Full Text] [Related]
2. Effect of lumican on the migration of human mesenchymal stem cells and endothelial progenitor cells: involvement of matrix metalloproteinase-14.
Malinowski M; Pietraszek K; Perreau C; Boguslawski M; Decot V; Stoltz JF; Vallar L; Niewiarowska J; Cierniewski C; Maquart FX; Wegrowski Y; Brézillon S
PLoS One; 2012; 7(12):e50709. PubMed ID: 23236386
[TBL] [Abstract][Full Text] [Related]
3. Lumican affects tumor cell functions, tumor-ECM interactions, angiogenesis and inflammatory response.
Nikitovic D; Papoutsidakis A; Karamanos NK; Tzanakakis GN
Matrix Biol; 2014 Apr; 35():206-14. PubMed ID: 24060754
[TBL] [Abstract][Full Text] [Related]
4. Lumican core protein inhibits melanoma cell migration via alterations of focal adhesion complexes.
Brézillon S; Radwanska A; Zeltz C; Malkowski A; Ploton D; Bobichon H; Perreau C; Malicka-Blaszkiewicz M; Maquart FX; Wegrowski Y
Cancer Lett; 2009 Sep; 283(1):92-100. PubMed ID: 19394140
[TBL] [Abstract][Full Text] [Related]
5. Lumican - derived peptides inhibit melanoma cell growth and migration.
Pietraszek K; Brézillon S; Perreau C; Malicka-Błaszkiewicz M; Maquart FX; Wegrowski Y
PLoS One; 2013; 8(10):e76232. PubMed ID: 24098450
[TBL] [Abstract][Full Text] [Related]
6. Lumican, a small leucine-rich proteoglycan substituted with keratan sulfate chains is expressed and secreted by human melanoma cells and not normal melanocytes.
Sifaki M; Assouti M; Nikitovic D; Krasagakis K; Karamanos NK; Tzanakakis GN
IUBMB Life; 2006 Oct; 58(10):606-10. PubMed ID: 17050378
[TBL] [Abstract][Full Text] [Related]
7. Microenvironmental Modulation of Decorin and Lumican in Temozolomide-Resistant Glioblastoma and Neuroblastoma Cancer Stem-Like Cells.
Farace C; Oliver JA; Melguizo C; Alvarez P; Bandiera P; Rama AR; Malaguarnera G; Ortiz R; Madeddu R; Prados J
PLoS One; 2015; 10(7):e0134111. PubMed ID: 26230845
[TBL] [Abstract][Full Text] [Related]
8. Lumican is a major small leucine-rich proteoglycan (SLRP) in Atlantic cod (Gadus morhua L.) skeletal muscle.
Tingbø MG; Pedersen ME; Kolset SO; Enersen G; Hannesson KO
Glycoconj J; 2012 Jan; 29(1):13-23. PubMed ID: 22124673
[TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of lumican inhibited the attachment and growth of human embryonic kidney 293 cells.
Ishiwata T; Yamamoto T; Kawahara K; Kawamoto Y; Matsuda Y; Ishiwata S; Naito Z
Exp Mol Pathol; 2010 Jun; 88(3):363-70. PubMed ID: 20138170
[TBL] [Abstract][Full Text] [Related]
10. The small leucine-rich proteoglycan lumican inhibits melanoma progression.
Vuillermoz B; Khoruzhenko A; D'Onofrio MF; Ramont L; Venteo L; Perreau C; Antonicelli F; Maquart FX; Wegrowski Y
Exp Cell Res; 2004 Jun; 296(2):294-306. PubMed ID: 15149859
[TBL] [Abstract][Full Text] [Related]
11. Lumican Inhibits SNAIL-Induced Melanoma Cell Migration Specifically by Blocking MMP-14 Activity.
Stasiak M; Boncela J; Perreau C; Karamanou K; Chatron-Colliet A; Proult I; Przygodzka P; Chakravarti S; Maquart FX; Kowalska MA; Wegrowski Y; Brézillon S
PLoS One; 2016; 11(3):e0150226. PubMed ID: 26930497
[TBL] [Abstract][Full Text] [Related]
12. Lumican: a new inhibitor of matrix metalloproteinase-14 activity.
Pietraszek K; Chatron-Colliet A; Brézillon S; Perreau C; Jakubiak-Augustyn A; Krotkiewski H; Maquart FX; Wegrowski Y
FEBS Lett; 2014 Nov; 588(23):4319-24. PubMed ID: 25304424
[TBL] [Abstract][Full Text] [Related]
13. Lumican expression, localization and antitumor activity in prostate cancer.
Coulson-Thomas VJ; Coulson-Thomas YM; Gesteira TF; Andrade de Paula CA; Carneiro CR; Ortiz V; Toma L; Kao WW; Nader HB
Exp Cell Res; 2013 Apr; 319(7):967-81. PubMed ID: 23399832
[TBL] [Abstract][Full Text] [Related]
14. Lumican effects in the control of tumour progression and their links with metalloproteinases and integrins.
Brézillon S; Pietraszek K; Maquart FX; Wegrowski Y
FEBS J; 2013 May; 280(10):2369-81. PubMed ID: 23438179
[TBL] [Abstract][Full Text] [Related]
15. Lumican, a small leucine-rich proteoglycan.
Nikitovic D; Katonis P; Tsatsakis A; Karamanos NK; Tzanakakis GN
IUBMB Life; 2008 Dec; 60(12):818-23. PubMed ID: 18949819
[TBL] [Abstract][Full Text] [Related]
16. Identification of beta1 integrin as mediator of melanoma cell adhesion to lumican.
D'Onofrio MF; Brézillon S; Baranek T; Perreau C; Roughley PJ; Maquart FX; Wegrowski Y
Biochem Biophys Res Commun; 2008 Jan; 365(2):266-72. PubMed ID: 17981144
[TBL] [Abstract][Full Text] [Related]
17. Lumican inhibits cell migration through α2β1 integrin.
Zeltz C; Brézillon S; Käpylä J; Eble JA; Bobichon H; Terryn C; Perreau C; Franz CM; Heino J; Maquart FX; Wegrowski Y
Exp Cell Res; 2010 Oct; 316(17):2922-31. PubMed ID: 20705068
[TBL] [Abstract][Full Text] [Related]
18. Expression of lumican, a small leucine-rich proteoglycan with antitumour activity, in human malignant melanoma.
Brézillon S; Venteo L; Ramont L; D'Onofrio MF; Perreau C; Pluot M; Maquart FX; Wegrowski Y
Clin Exp Dermatol; 2007 Jul; 32(4):405-16. PubMed ID: 17490399
[TBL] [Abstract][Full Text] [Related]
19. Degradation of small leucine-rich repeat proteoglycans by matrix metalloprotease-13: identification of a new biglycan cleavage site.
Monfort J; Tardif G; Reboul P; Mineau F; Roughley P; Pelletier JP; Martel-Pelletier J
Arthritis Res Ther; 2006; 8(1):R26. PubMed ID: 16507124
[TBL] [Abstract][Full Text] [Related]
20. Small Leucine Rich Proteoglycans (decorin, biglycan and lumican) in cancer.
Appunni S; Anand V; Khandelwal M; Gupta N; Rubens M; Sharma A
Clin Chim Acta; 2019 Apr; 491():1-7. PubMed ID: 30629950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
